Dx Deals: Quest Makes Big North American Expansion with LifeLabs Acquisition
The roughly $1 billion deal will boost the company’s annual revenue by about 7 percent, and will give Quest a stronger presence in Canada.
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
The roughly $1 billion deal will boost the company’s annual revenue by about 7 percent, and will give Quest a stronger presence in Canada.
From - Laboratory Industry Report
After last month's flurry of transactions, business calmed down as it often does during the start of summer. Here are the key deals and trends from…
From - National Intelligence Report
Consumer-based genetic testing has become a $3 billion business with a seemingly limitless future. But the industry is also facing a legal threat to future growth…
From - G2 Compliance Advisor
Safeguarding personal health information (PHI) data from hackers, identity thieves and other cyber threats isn't just a legal obligation but…
By Chance Scott bio
The publication of the 2018 Clinical Laboratory Fee Schedule (CLFS) in January saw a long and heated debate within the lab community come to fruition…
From - G2 Compliance Advisor
Roughly three years ago at this time, mega-scandals were in the news featuring diagnostic giants like Millennium, Health Diagnostic Laboratory (HDL), Biodiagnostic Laboratory Service and…
From - Laboratory Industry Report
One quarter into its existence, the new PAMA Medicare Part B fee schedule seems to be having only a marginal impact on at least publicly traded labs…
From - Laboratory Industry Report
Here's a rundown of the key diagnostic product launches from mid-May through the third week of June…
From - National Intelligence Report
After decades of complaining about the Stark Law, the lab industry may now have an actual opportunity to secure meaningful relief…